Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors
2001
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
The history of cancer epigenetics
2004 Standout
Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis
1994
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Triggering and modulation of apoptosis by oxidative stress
2000 Standout
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia
1994
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Amphotericin B Nephrotoxicity in Children
2004
21q22 balanced chromosome aberrations in therapy‐related hematopoietic disorders: Report from an International Workshop†
2002
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation
2004
Low-dose dopamine: a systematic review
2002
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
Vascular disorders of the liver # †
2008 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: Incidence, risk factors, and outcome
1999
Molecular mechanisms of cisplatin resistance
2011 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Acute myeloid leukaemia
2006
Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
1991
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
2001
Acute Myeloid Leukemia and the Position of Autologous Stem Cell Transplantation
2007
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 StandoutNobel
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Pharmacokinetics of Once-Daily IV Busulfan as Part of Pretransplantation Preparative Regimens: A Comparison with an Every 6-Hour Dosing Schedule
2007
Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants
2006
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Cardiorenal Syndrome
2008 Standout
The myelodysplastic syndrome.
1989
Translation of new cancer treatments from pet dogs to humans
2008 Standout
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Pulmonary Complications in Adult Blood and Marrow Transplant Recipients
2005
Hematopoietic Stem-Cell Transplantation
2006 Standout
Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging
2009 Standout
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality
2002
Growth factors in acute myeloid leukaemia
2001
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995)
2004
An analysis of 8305 cases of carcinoid tumors
2000 Standout
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients
2012
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation
2000
Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation
2007
Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and Tumors
2003
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid‐organ transplant recipients with invasive fungal infections
2000
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity
2003
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial
2002
A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan
2002
Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients
2007
Th1/Th2 in aspergillosis
2006
Induction of apoptosis in human mitogen‐activated peripheral blood T‐lymphocytes by the ether phospholipid ET‐18‐OCH 3 : Involvement of the Fas receptor/ligand system
1999
Satraplatin: an orally available platinum analog for the treatment of cancer
2006
Treatment of Acute Myeloid Leukemia with Cytokines: Effect on Duration of Neutropenia and Response to Infections
1998
Acute decompensated heart failure and the cardiorenal syndrome
2008
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Flow cytometric analysis of cell‐surface and intracelluar antigens in leukemia diagnosis
1994
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
2007
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Coadministration of Histone Deacetylase Inhibitors and Perifosine Synergistically Induces Apoptosis in Human Leukemia Cells through Akt and ERK1/2 Inactivation and the Generation of Ceramide and Reactive Oxygen Species
2005
Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis
1993
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS
2004
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death
2005
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
1999 Standout
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
1996 Standout
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
In vivo GM-CSF prevents dexamethasone suppression of killing ofAspergillus fumigatusconidia by bronchoalveolar macrophages
2001
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways
2006
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias
1998
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells
2007 Standout
Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial.
1999
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Mechanisms of Cancer Drug Resistance
2002 Standout
Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.
1999
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias
1998
Nomenclature of monocytes and dendritic cells in blood
2010 Standout
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants
2003
Aspergillus fumigatusand Aspergillosis
1999 Standout
Practical modalities for prevention of fungal infections in cancer patients
1997
Systemic Antifungal Agents
1998
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
Carcinoid Tumors of the Gut
1997
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial
2002
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
Metal–Organic Frameworks in Biomedicine
2011 Standout
Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
2002
Guidelines for Treatment of Candidiasis
2004 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Treatment of Therapy-Related Leukemia and Myelodysplastic Syndrome
1993
Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression
1993
Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor
1998
High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival
2005
Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients
1994
Works of Robert B. Geller being referenced
Oral Chemotherapy Agents in the Treatment of Leukaemia
1999
A Phase II Trial of Autologous Bone Marrow Transplantation (ABMT) in Acute Leukemia with Edelfosine Purged Bone Marrow
1996
Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy‐induced diarrhea in bone marrow transplant and leukemia patients
1995
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.
1996
Consensus statement: Octreotide dose titration in secretory diarrhea
1995
Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research
2006
Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
1996
Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease.
1988
EVALUATION OF THE DRUG INTERACTION BETWEEN INTRAVENOUS HIGH-DOSE FLUCONAZOLE AND CYCLOSPORINE OR TACROLIMUS IN BONE MARROW TRANSPLANT PATIENTS
1996
Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10)
1990
A Pilot Study of Prophylactic Aerosolized Amphotericin B In Patients at Risk for Prolonged Neutropenia
1992
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.
2000
Efficacy of Low-Dose Dopamine in Preventing Amphotericin B Nephrotoxicity in Bone Marrow Transplant Patients and Leukemia Patients
1998
Association of busulfan area under the curve with veno-occlusive disease following BMT.
1996
Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation.
1992